(Q43209819)

16 November 2017

title

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine (English)

1 reference

16 November 2017

main subject

visceral leishmaniasis

1 reference

1 reference

5

1 reference

16 November 2017

D Kumar

1

1 reference

16 November 2017

V Ramesh

series ordinal

2

1 reference

16 November 2017

S Verma

series ordinal

3

1 reference

16 November 2017

M Ramam

series ordinal

4

1 reference

16 November 2017

publication date

1 December 2009

1 reference

Annals of Tropical Medicine and Parasitology

16 November 2017

published in

1 reference

16 November 2017

volume

103

1 reference

16 November 2017

issue

8

1 reference

16 November 2017

page(s)

727-730

1 reference

Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Post-kala-azar dermal leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

Elevated levels of interferon-γ, interleukin-10, and interleukin-6 during active disease in Indian kala azar

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12554106963438

10.1179/000349809X12554106963438

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference